Pharmaceutical science to improve the human condition : Prix Galien 2010 : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010
著者
書誌事項
Pharmaceutical science to improve the human condition : Prix Galien 2010 : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010
（Annals of the New York Academy of Sciences, v. 1222）
Wiley Periodicals, c2011
- タイトル別名
-
Prix Galien 2010
Winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010
大学図書館所蔵 全1件
注記
Caption title
Includes bibliographical references
HTTP:URL=http://www.loc.gov/catdir/enhancements/fy1210/2012359217-d.html Information=Publisher description
収録内容
- Foreword
- Ban Ki-Moon
- Prix Galien Pro Bono Humanitarian Award Winner : Philippe Douste-Blazy
- Philippe Douste-Blazy
- Prix Galien Pro Bono Humanitarian Award Winner : William J. Clinton
- William J. Clinton
- Advances in the diagnosis of respiratory tract infections : role of the Luminex xTAG respiratory viral panel
- Nancy Krunic ... [et al.]
- Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine
- Michelle G. Goveia ... [et al.]
- Novartis Malaria Initiative : best practice example of pharmaceutical industry's engagement in the fight against malaria
- Gilbert Lefèvre, Anne Claire Marrast, and Heiner Grueninger
- Development of the IL-12/23 antagonist ustekinumab in psoriasis : past, present, and future perspectives
- Newman Yeilding ... [et al.]
- Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
- Richard Hargreaves ... [et al.]
- Linezolid, the first oxazolidinone antibacterial agent
- Karen L. Leach ... [et al.]
- The development of romiplostim for patients with immune thrombocytopenia / Graham Molineux
- The discovery and development of rivaroxaban
- Frank Misselwitz, Scott D. Berkowitz, and Elisabeth Perzborn
- A review of the history, properties, and use of the immunomodulatory compound lenalidomide
- Jerome B. Zeldis ... [et al.]
- Raltegravir : the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium
- Bach-Yen T. Nguyen ... [et al.]
- Innovation in coronary artery disease and heart failure : clinical benefits of pure heart rate reduction with ivabradine
- Emmanuel Canet, Guy Lerebours, and Jean-Paul Vilaine
内容説明・目次
内容説明
This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Bro Bono Humanitarian Awards (http://www.prix-galien-usa.com/index.php). The Prix Galien was created in France by pharmacist Roland Mehl, whose aim was to promote the country's significant advances in pharmaceutical research. Until the establishment of the Prix Galien, this discipline was unrecognized. Mehl brought together an eminent jury of clinicians, toxicologists, pharmacologists, and pharmacists to select and honor the most important drugs introduced to the public market and the most significant research teams in the pharmaceutical field. Since then, the Prix Galien has been introduced across Europe and Canada, and is now the most prestigious award of its kind in 11 countries. In addition, an International Prix Galien award is given each year, selected from previous winners.
Contributions in the present volume - from top researchers in the biopharmaceutical industry, and the esteemed Bro Bono Humanitarian award winners President William Clinton and Dr. Philippe Douste-Blasy, with a special introduction by Secretary-General of the United Nations Ban Ki-moon - best embody humanitarianism and therapeutic promise in global healthcare problems. Winners and select finalists of the 2010 Prix Galien prizes represent biotechnical advances poised to combat a wide range of diseases and viruses.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please click here.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
「Nielsen BookData」 より